Back to Search
Start Over
[Rhabdomyolysis due to drug-drug interaction of atorvastatin and cobicistat].
- Source :
-
Innere Medizin (Heidelberg, Germany) [Inn Med (Heidelb)] 2022 Nov; Vol. 63 (11), pp. 1189-1193. Date of Electronic Publication: 2022 Aug 24. - Publication Year :
- 2022
-
Abstract
- A 53-year-old man presented with rhabdomyolysis and acute kidney injury. The symptoms were presumably caused by a drug-drug interaction between an antiretroviral drug combination and atorvastatin. As a booster, cobicistat can also increase the toxicity of statins via inhibition of the enzyme cytochrome p450 3A4 (CYP3A4). After stopping atorvastatin and after intravenous fluid therapy, the symptoms regressed completely.<br /> (© 2022. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.)
Details
- Language :
- German
- ISSN :
- 2731-7099
- Volume :
- 63
- Issue :
- 11
- Database :
- MEDLINE
- Journal :
- Innere Medizin (Heidelberg, Germany)
- Publication Type :
- Academic Journal
- Accession number :
- 36001111
- Full Text :
- https://doi.org/10.1007/s00108-022-01377-x